About EffRx

EffRx Pharmaceuticals SA is an innovative specialty pharmaceutical company focused on the development of novel therapeutic entities for a variety of orphan and specialty indications. Our goal is to improve the quality of life of patients with unmet medical needs.

 

Pipeline

The product portfolio is led by already launched Binosto® for the treatment of postmenopausal osteoporosis. EffRx is currently further expanding its product pipeline. The lead development product, EX404, targets polycystic ovarian syndrome (PCOS) in adolescents.

 
 

© 2014 EffRx Pharmaceuticals